Wheeler Financial from Pitney Bowes has closed a financing transaction with Aspirar Medical Lab. The medical testing company, located in Cary, North Carolina, is investing the funding in new laboratory equipment and software to extend the services it offers to its clients, including COVID-19 testing.

Serving physicians and medical practices, Aspirar Medical Lab provides services in pain management, drug testing, therapeutic drug monitoring and medical surveillance. To meet increased demand and continue to deliver superior services to its clients, the company is investing in cutting-edge screening technologies. With a need to finance both the testing equipment and software to deliver detailed, meaningful and precise analytics, Aspirar Medical Labs partnered with Wheeler Financial from Pitney Bowes.

“Investing in new screening technologies is key to delivering the precision and consistency our clients need. Combining these technologies with high-performance software has been critical in our new testing capabilities including COVID-19 testing,” said Pick Chay, CEO from Aspirar Medical Lab.

“Businesses like Aspirar Medical Lab must invest in technology to manage demand, to drive growth and to meet stringent regulatory standards, but banks are making it harder and harder for them to access capital,” said Christopher Johnson, senior vice president and president, Pitney Bowes Financial Services. “Businesses need affordable finance and flexible terms from a provider with a robust history of lending. They need a service personalized to their specific circumstances and deep insight into their specific industry. With Wheeler Financial from Pitney Bowes, Aspirar Medical Lab has access to all this, backed up with 100 years’ experience supporting small businesses.”